Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

34.33
+0.53131.57%
Volume:315
Turnover:10.77K
Market Cap:32.61M
PE:- -
High:34.33
Open:34.33
Low:34.33
Close:33.80
52wk High:36.72
52wk Low:25.59
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.06
T/O Rate:0.03%
Dividend:0.16
Dividend Rate:0.47%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

UnitedHealth Group (UNH), Why Is The Market Paying Closer Attention Now?

Simply Wall St.
·
Aug 30

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

TIPRANKS
·
Aug 29

UnitedHealth, Strategy, Home Depot, Rocket Lab, Applied Shock

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Reuters
·
Aug 28

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Reuters
·
Aug 28

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

TIPRANKS
·
Aug 28

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

Reuters
·
Aug 28

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS
·
Aug 28

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares

Reuters
·
Aug 28